Maternal use of nicotine products and breastfeeding 3 months postpartum
- PMID: 32274823
- DOI: 10.1111/apa.15299
Maternal use of nicotine products and breastfeeding 3 months postpartum
Abstract
Aim: We aimed to determine the prevalence of and factors associated with maternal use of nicotine products in relation to breastfeeding.
Methods: Nicotine use 3 months postpartum was determined in the Scandinavian PreventADALL mother-child birth cohort study recruiting 1837 women from 2014 to 2016. Electronic questionnaires at 18 weeks pregnancy and 3 months postpartum provided information on snus use, smoking or other nicotine use, infant feeding and socio-economic factors. The risk of nicotine use in relation to breastfeeding was analysed with logistic regression.
Results: Overall, 5.6% of women used snus (2.9%), smoked (2.7%) or both (n = 2) 3 months postpartum, while one used other nicotine products. Among the 1717 breastfeeding women, 95.1% reported no nicotine use, while 2.4% used snus, 2.5% smoked and one dual user. Compared to 3.7% nicotine use in exclusively breastfeeding women (n = 1242), the risk of nicotine use increased by partly (OR 2.26, 95% CI 1.45-3.52) and no breastfeeding (OR 4.58, 95% CI 2.57-8.21). Nicotine use before (14.5% snus, 16.4% smoking) or in pregnancy (0.2% snus, 0.4% smoking) significantly increased the risk of using nicotine during breastfeeding.
Conclusion: Few breastfeeding women used snus or smoked 3 months postpartum, with increased risk by nicotine use before or during pregnancy.
Keywords: birth cohort; breastfeeding; maternal smoking; pregnancy; snus use.
© 2020 The Authors. Acta Paediatrica published by John Wiley & Sons Ltd on behalf of Foundation Acta Paediatrica.
References
REFERENCES
-
- The Global Burden of Diseases I, and Risk Factors Study (GBD). Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015. Lancet. 2017;389(10082):1885-1906.
-
- Kreyberg I, Nordhagen LS, Bains KES, et al. An update on prevalence and risk of snus and nicotine replacement therapy during pregnancy and breastfeeding. Acta Paediatr. 2019;108:1215-1221.
-
- Inamdar AS, Croucher RE, Chokhandre MK, Mashyakhy MH, Marinho VC. Maternal smokeless tobacco use in pregnancy and adverse health outcomes in newborns: a systematic review. Nicotine Tob Res. 2015;17(9):1058-1066.
-
- Dahlstrom A, Ebersjo C, Lundell B. Nicotine exposure in breastfed infants. Acta Paediatr. 2004;93(6):810-816.
-
- Nordenstam F, Lundell B, Edstedt Bonamy AK, Raaschou P, Wickström R. Snus users had high levels of nicotine, cotinine and 3-hydroxycotinine in their breastmilk, and the clearance was slower than in smoking mothers. Acta Paediatr. 2019;108:1250-1255.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical